Piper Sandler Upgrades Immunogen Inc. (IMGN) to Overweight
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 23 | New: 28
Rating Summary:
5 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 23 | New: 28
Join SI Premium – FREE
Piper Sandler analyst Joseph Catanzaro upgraded Immunogen Inc. (NASDAQ: IMGN) from Neutral to Overweight with a price target of $16.00.
For an analyst ratings summary and ratings history on Immunogen Inc. click here. For more ratings news on Immunogen Inc. click here.
Shares of Immunogen Inc. closed at $5.20 yesterday.
You May Also Be Interested In
- Barclays Upgrades Lincoln National (LNC) to Overweight
- Kepler Cheuvreux Upgrades Quilter Plc. (QLT:LN) to Buy
- Kepler Cheuvreux Upgrades Societe Generale SA (GLE:FP) (SCGLY) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
